| 000 | 01734 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250511215642.0 | ||
| 264 | 0 | _c19910426 | |
| 008 | 199104s 0 0 eng d | ||
| 022 | _a0171-5216 | ||
| 024 | 7 |
_a10.1007/BF01613139 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarkman, M | |
| 245 | 0 | 0 |
_aPhase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _c1991 |
||
| 300 |
_a151-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntidotes _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aCisplatin _xadverse effects |
| 650 | 0 | 4 | _aDrug Combinations |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHearing _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aKidney _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aThiosulfates _xadverse effects |
| 650 | 0 | 4 |
_aVomiting _xchemically induced |
| 700 | 1 | _aD'Acquisto, R | |
| 700 | 1 | _aIannotti, N | |
| 700 | 1 | _aKris, M | |
| 700 | 1 | _aHakes, T | |
| 700 | 1 | _aBajorin, D | |
| 700 | 1 | _aBosl, G | |
| 700 | 1 | _aReichman, B | |
| 700 | 1 | _aCasper, E | |
| 700 | 1 | _aMagill, G | |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 117 _gno. 2 _gp. 151-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01613139 _zAvailable from publisher's website |
| 999 |
_c2013795 _d2013795 |
||